Prime Medicine, Inc. EFFECT, filed Mar 4, 2026: primary_doc.xml
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 4, 2026 |
| Accession Number: | 0001894562-26-000009 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||